|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N2740/16122 | (2013.01) |
| C07H 21/04 | (2006.01) | ||
| C07K 14/00 | (2006.01) | ||
| C12N2740/16134 | (2013.01) | ||
| C12N2740/16222 | (2013.01) | ||
| C12N2740/16234 | (2013.01) | ||
| C12N2740/16322 | (2013.01) | ||
| C12N2740/16334 | (2013.01) | ||
| A61K 39/12 | (2013.01) | ||
| A61K2039/523 | (2013.01) | ||
| A61K2039/53 | (2013.01) | ||
| C12N2710/20034 | (2013.01) | ||
| C12N2760/16134 | (2013.01) | ||
| C12N2770/24234 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K2039/54 | (2013.01) | ||
| A61K2039/55538 | (2013.01) | ||
| A61K2039/585 | (2013.01) | ||
| C07K 14/005 | (2013.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 31/16 | (2018.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61P 31/20 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61K 39/001157 | (2018.08) |
| (11) | Number of the document | 3907232 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21163008.2 |
| Date of filing the European patent application | 2007-07-30 | |
| (97) | Date of publication of the European application | 2021-11-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 83385606 P | 2006-07-28 | US | |
| 83386106 P | 2006-07-28 | US | |
| 89035207 P | 2007-02-16 | US |
| (72) |
WEINER, David B. , US
YAN, Jian , US
|
| (73) |
The Trustees of the University of Pennsylvania ,
3160 Chestnut Street, Suite 200, Philadelphia, PA 19104-6283,
US
|
| (54) | IMPROVED HIV VACCINES |
| IMPROVED HIV VACCINES |